IL159841A0 - Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions - Google Patents
Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functionsInfo
- Publication number
- IL159841A0 IL159841A0 IL15984102A IL15984102A IL159841A0 IL 159841 A0 IL159841 A0 IL 159841A0 IL 15984102 A IL15984102 A IL 15984102A IL 15984102 A IL15984102 A IL 15984102A IL 159841 A0 IL159841 A0 IL 159841A0
- Authority
- IL
- Israel
- Prior art keywords
- decline
- damage
- treatment
- cognitive functions
- pharmaceutical composition
- Prior art date
Links
- 230000003920 cognitive function Effects 0.000 title abstract 2
- 230000007423 decrease Effects 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000003340 mental effect Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0103017A HUP0103017A3 (en) | 2001-07-18 | 2001-07-18 | Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use |
| PCT/HU2002/000069 WO2003007926A2 (en) | 2001-07-18 | 2002-07-18 | Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL159841A0 true IL159841A0 (en) | 2004-06-20 |
Family
ID=90001562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15984102A IL159841A0 (en) | 2001-07-18 | 2002-07-18 | Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20040171696A1 (xx) |
| EP (1) | EP1408940B1 (xx) |
| JP (1) | JP2004537548A (xx) |
| KR (1) | KR20040017326A (xx) |
| CN (1) | CN1545410A (xx) |
| AT (1) | ATE408403T1 (xx) |
| CA (1) | CA2453834A1 (xx) |
| CZ (1) | CZ200460A3 (xx) |
| DE (1) | DE60228968D1 (xx) |
| EA (1) | EA006897B1 (xx) |
| HU (1) | HUP0103017A3 (xx) |
| IL (1) | IL159841A0 (xx) |
| PL (1) | PL365258A1 (xx) |
| RS (1) | RS4904A (xx) |
| SK (1) | SK312004A3 (xx) |
| UA (1) | UA78714C2 (xx) |
| WO (1) | WO2003007926A2 (xx) |
| ZA (1) | ZA200400481B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0301537A3 (en) * | 2003-06-03 | 2005-07-28 | Egis Gyogyszergyar Nyilvanosan | Deramcyclane fumarate tablets and process for producing them |
| HUP0301906A3 (en) * | 2003-06-23 | 2006-03-28 | Egis Gyogyszergyar Nyilvanosan | Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity |
| EP1500391A1 (en) * | 2003-07-24 | 2005-01-26 | Neuro3D | Therapeutic use of bicycloheptane derivatives |
| CZ2006623A3 (cs) * | 2004-03-12 | 2007-01-24 | Egis Gyogyszergyár Nyrt. | Kombinace deramciklanu a opioidů jako analgetik |
| US20080021016A1 (en) * | 2004-03-12 | 2008-01-24 | Levay Gyoergy | Combined Pharmaceutical Composition for the Inhibition of the Decline of Cognitive Functions |
| KR101642113B1 (ko) | 2014-10-08 | 2016-07-25 | 원광대학교산학협력단 | 퇴행성 뇌질환을 예방, 개선 또는 치료하는 유황의 법제 방법 및 상기 방법으로 법제된 유황 |
| US11478467B2 (en) | 2017-05-04 | 2022-10-25 | Sreenivasarao Vepachedu | Targeted drug rescue with novel compositions, combinations, and methods thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU179164B (en) * | 1979-12-14 | 1982-08-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing cycloalkyl-ethers of alkanolamines |
| HU226061B1 (en) * | 1996-10-17 | 2008-04-28 | Egis Gyogyszergyar Nyilvanosan | 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation |
| HU227114B1 (en) * | 1999-05-11 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same |
| US6335371B1 (en) * | 2000-11-28 | 2002-01-01 | Orion Corporation | Method for inducing cognition enhancement |
-
2001
- 2001-07-18 HU HU0103017A patent/HUP0103017A3/hu unknown
-
2002
- 2002-07-18 SK SK31-2004A patent/SK312004A3/sk not_active Application Discontinuation
- 2002-07-18 CA CA002453834A patent/CA2453834A1/en not_active Abandoned
- 2002-07-18 CN CNA028163729A patent/CN1545410A/zh active Pending
- 2002-07-18 WO PCT/HU2002/000069 patent/WO2003007926A2/en active IP Right Grant
- 2002-07-18 IL IL15984102A patent/IL159841A0/xx unknown
- 2002-07-18 CZ CZ200460A patent/CZ200460A3/cs unknown
- 2002-07-18 RS YU4904A patent/RS4904A/sr unknown
- 2002-07-18 AT AT02745700T patent/ATE408403T1/de not_active IP Right Cessation
- 2002-07-18 EP EP02745700A patent/EP1408940B1/en not_active Expired - Lifetime
- 2002-07-18 US US10/483,808 patent/US20040171696A1/en not_active Abandoned
- 2002-07-18 EA EA200400192A patent/EA006897B1/ru not_active IP Right Cessation
- 2002-07-18 DE DE60228968T patent/DE60228968D1/de not_active Expired - Fee Related
- 2002-07-18 PL PL02365258A patent/PL365258A1/xx not_active Application Discontinuation
- 2002-07-18 JP JP2003513535A patent/JP2004537548A/ja active Pending
- 2002-07-18 KR KR10-2004-7000792A patent/KR20040017326A/ko active IP Right Grant
- 2002-07-18 UA UA2004021167A patent/UA78714C2/uk unknown
-
2004
- 2004-01-22 ZA ZA200400481A patent/ZA200400481B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60228968D1 (de) | 2008-10-30 |
| HUP0103017A2 (hu) | 2003-07-28 |
| HUP0103017D0 (en) | 2001-10-28 |
| RS4904A (xx) | 2006-10-27 |
| UA78714C2 (en) | 2007-04-25 |
| EP1408940A2 (en) | 2004-04-21 |
| CN1545410A (zh) | 2004-11-10 |
| US20040171696A1 (en) | 2004-09-02 |
| CA2453834A1 (en) | 2003-01-30 |
| HUP0103017A3 (en) | 2004-05-28 |
| EA200400192A1 (ru) | 2004-06-24 |
| WO2003007926A3 (en) | 2003-09-18 |
| CZ200460A3 (cs) | 2004-05-12 |
| ATE408403T1 (de) | 2008-10-15 |
| WO2003007926A2 (en) | 2003-01-30 |
| SK312004A3 (en) | 2004-06-08 |
| KR20040017326A (ko) | 2004-02-26 |
| PL365258A1 (en) | 2004-12-27 |
| EA006897B1 (ru) | 2006-04-28 |
| ZA200400481B (en) | 2005-01-24 |
| EP1408940B1 (en) | 2008-09-17 |
| JP2004537548A (ja) | 2004-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2407100A1 (en) | 1-aroyl-piperidinyl benzamidines | |
| MY136761A (en) | Oxazol derivatives | |
| TWI255807B (en) | Therapeutic agents | |
| MY138252A (en) | Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease | |
| WO2004013120A8 (en) | Novel benzodioxoles | |
| IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
| MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
| MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| DE602004011394D1 (en) | Thiazolderivate | |
| TW200740787A (en) | (6-Fluoro-benzo[1,3]dioxolyl)-morpholin-4-yl-methanones | |
| DE60112330D1 (en) | Pyrazolopyridinderivate | |
| MY135218A (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases | |
| DE602004011966D1 (en) | Heterocyclylverbindungen | |
| YU87202A (sh) | Derivati arilmetilamina koji se koriste kao inhibitori triptaze | |
| ES2186550A1 (es) | Nuevos derivados de oxazolidinonas como antibacterianos. | |
| RS44204A (xx) | Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1 | |
| IL159412A0 (en) | A synergistic pharmaceutical combination for the prevention or treatment of diabetes | |
| MY141020A (en) | Novel pparalpha and ppargamma agonists | |
| IL159841A0 (en) | Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions | |
| GB0212410D0 (en) | Organic compounds | |
| RS44304A (xx) | Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1 | |
| DE60201074D1 (en) | Pyrazolopyridinderivate | |
| RS20050954A (xx) | Upotreba derivata biciklo/2.2.1/heptana za pripremanje neurozaštitnih farmaceutskih preparata |